Plasma lysozyme level and reticuloendothelial system function in human liver disease.
Plasma lysozyme levels have been reported to reflect the functional status of the reticuloendothelial system (RES). We measured plasma lysozyme levels in 22 patients with acute hepatitis and 21 patients with cirrhosis and a mesocaval shunt. In 17 of these patients RES function was assessed by measuring the disappearance rate (t/2) of radio-labelled sulphur colloid. In acute hepatitis plasma lysozyme levels and colloid t/2 were significantly lower than in health controls and cirrhotics. In the acute hepatitis patients, the plasma lysozyme levels rose significantly two weeks after admission as the hepatitis improved. The colloid t/2 of the 17 patients with liver disease was significantly correlated with the plasma lysozyme level (r = +0.66, p = 0.005). These results suggest that in human liver disease, in comparison with animal experiments, plasma lysozyme is dependent on RES functional status in the sense that a more active RES will result in a lower lysozyme level.
D000208:Acute Disease; D000328:Adult; D000368:Aged; D005260:Female; D006505:Hepatitis / Q000201:enzymology* / Q000503:physiopathology; D006801:Humans; D008103:Liver Cirrhosis / Q000201:enzymology* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D012157:Mononuclear Phagocyte System / Q000502:physiology*; D009113:Muramidase / Q000097:blood*; D013455:Sulfur / Q000378:metabolism; D013667:Technetium / Q000378:metabolism; D013671:Technetium Tc 99m Sulfur Colloid
D013671:Technetium Tc 99m Sulfur Colloid; D013455:Sulfur; D013667:Technetium; D009113:Muramidase